Skip to main content
Membership NewsMembership News Archive

MHRA MedTech Regulatory Reform Webinar recording

The MHRA have released the recording of the MedTech Regulatory Reform Webinar, which took place on 5 March 2024. The webinar covered the intentions regarding scope, classification of general medical devices and IVDs, essential requirements and information to be provided with medical devices. You can access it here or below. https://www.youtube.com/watch?v=KjwOfdj14jo
Ben Kemp
April 2, 2024
HighlightsHighlights Archive

Media Monitoring: 28 March – 3 April

AI could predict patients' future health conditions, study finds The AI tool, known as Foresight, belongs to the same family of AI models as ChatGPT but has been trained using information from NHS electronic records. It was developed by researchers from King's College London (KCL), University College London (UCL), King's College Hospital NHS Foundation Trust and Guy's and St Thomas'…
Ben Kemp
April 2, 2024
HighlightsHighlights Archive

Breakthrough in motor neurone disease detection

Scientists are touting a significant advancement in the fight against motor neurone disease (MND) with the development of a groundbreaking test capable of identifying indicators of the condition even before symptoms appear. Known as the TDP-43 aptamer, this innovative tool has the ability to detect damaged cell proteins present in brain tissue samples. These proteins serve as biomarkers for MND,…
Ben Kemp
April 2, 2024
HighlightsHighlights Archive

British regions buck trend of global investment drop in science and tech

Science and technology start-ups in regions across the UK broke global trends to grow private sector investment in 2023, according to new research. Businesses in Yorkshire and Humber saw a huge uplift of 20% in venture capital investment through the period, reaching new highs of over £200 million of investment in 2023. Welsh companies also attracted more investment in 2023,…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

Digital Working Party survey expected soon

Members should brace themselves for a survey linked to the relaunch of the Digital Working Party, which will be distributed imminently. We would greatly appreciate members' feedback as digital is such a crucial, multi-faceted topic for health, but which has hitherto struggled to maintain an established focus in previous Digital Working Parties. We would like to reach a healthy equilibrium…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

Private Sector Opportunity in Uruguay

We have received another request from the British Embassy in Uruguay, following their recent request for rapid dengue fever tests. A well-established Uruguayan company is looking for UK suppliers of: Human rapid tests for: RPR test for the Serodiagnosis of Syphilis TPHA Treponema pallidum hemagglutination ABO 0 system blood groups and RH factor Urinalysis strips Molecular Diagnosis. Sample to result RT PCR system.…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

BIVDA Board Member Profile: Jane Meaney

Jane Meaney, AMLo Biosciences, was elected to the BIVDA Board last month. In a new series for the BIVDA newsletter, we will be profiling each of our board members to ensure greater visibility for members. Learn more about Jane below: 'I am Chief Marketing Office at AMLo Biosciences, a spin-out from Newcastle University. AMLo is a rare female founded tech…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

BIVDA meet with MHRA’s senior leadership

On Thursday 28th March, BIVDA's Helen Dent, Mike Messenger, Stuart Angell and Paul Fisher met with Medicines and Healthcare products Regulatory Agency CEO Dame June Raine, co-chair Amanda Calvert, and members of their executive leadership. The meeting is part of a series of bilateral meetings between the MHRA and BIVDA to provide a high-level update on the top-level activities of the two…
Ben Kemp
April 2, 2024
Membership NewsMembership News Archive

The BIVDA Board and its Role

As announced at the AGM, the board has welcomed three new members for following three years. Kam Pooni, Glyconics, was successfully re-elected to the board, while Mark Jackman, DiaSorin, and Jane Meaney, AMLoBiosciences, have joined for the first time. The board consists of 15 elected representatives from BIVDA member companies alongside our President Angela Douglas and Chief Executive Helen Dent.…
Ben Kemp
March 27, 2024